GOALS: We assessed satisfaction with and adherence to off-label corticosteroids in patients with eosinophilic esophagitis (EoE) in the United States.
BACKGROUND: EoE is a chronic inflammatory disease, for which there are currently no US Food and Drug Administration-approved swallowed topical corticosteroids.
STUDY: This non-interventional, cross-sectional, web-based survey included caregivers of adolescents (aged 11-17 years) and adults (aged ≥ 18 years) with a self-reported (or caregiver-reported [adolescents]) physician diagnosis of EoE who were receiving corticosteroids. Participants were recruited via 2 non-profit, patient advocacy groups. The 9-item Treatment Satisfaction Questionnaire for Medication (TSQM-9) was used to assess satisfaction across effectiveness, convenience, and global satisfaction domains (scale: 1-100 per domain); higher scores indicated greater satisfaction. The 4-item Morisky Green Levine Medication Adherence Scale (MGL-4) was used to assess adherence; an MGL-4 score of < 3 indicated adherence. Participants also reported reasons for non-adherence.
RESULTS: Overall, 201 participants (caregivers of adolescents, n = 98; adults, n = 103) were included in this study. Mean TSQM-9 scores indicated low satisfaction with off-label corticosteroids across all 3 satisfaction domains in adolescents (≤ 61.1) and adults (≤ 55.7). Slightly fewer adolescents (37.1%) than adults (40.8%) were considered adherent. Forgetfulness was the most frequently reported reason for non-adherence; some patients chose not to take their medications, owing to poor palatability (adolescents), difficulty taking medications at specific times (adults), or feeling depressed/overwhelmed (adolescents and adults).
CONCLUSIONS: Satisfaction with and adherence to off-label corticosteroids were low in this web-based survey of adolescents and adults with EoE in the United States.
Gold BD, Goodwin B, Davis K, Sweeney C, Ziemiecki R, Jiang J, Fan T, Boules M, Chen ST, Katzka DA. Satisfaction with and adherence to off-label corticosteroids in adolescents and adults with eosinophilic esophagitis: results of a web-based survey in the United States. J Clin Gastroenterol. 2025 Feb;59(2):138-46. doi: 10.1097/MCG.0000000000002006
Related Therapeutic Areas